Monte Carlo study of radiation dose enhancement by gadolinium in megavoltage and high dose rate radiotherapy

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhang, Daniel G ^a   Feygelman, Vladimir ^b   Moros, Eduardo G ^b   Latifi, Kujtim ^b   Zhang, Geoffrey G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; GADOLINIUM TEXAPHYRIN; METALLOPORPHYRIN; RADIOSENSITIZING AGENT;

ARTICLE; BRACHYTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FLATTENED PHOTON BEAM; FLATTENING FILTER FREE PHOTON BEAM; MEGAVOLTAGE RADIOTHERAPY; MONTE CARLO METHOD; PHOTON THERAPY; QUANTITATIVE STUDY; RADIATION DOSE; RADIOTHERAPY EQUIPMENT; HUMAN; NEOPLASMS; PROCEDURES;

BRACHYTHERAPY; CONTRAST MEDIA; GADOLINIUM; HUMANS; METALLOPORPHYRINS; MONTE CARLO METHOD; NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 84907546565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109389     Document Type: Article

References (29)

1. Nasongkla N, Bey E, Ren J., Ai H, Khemtong C, et al (2006) Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Letters 6: 2427-2430.
2. Oerlemans C, Bult W, Bos M., Storm G, Nijsen JF, et al (2010) Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharmaceutical Research 27: 2569-2589.
3. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S., Aguinaldo JGS, et al. (2007) Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proceedings of the National Academy of Sciences 104: 961-966.
4. Evens AM (2004) Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer. Current Opinion in Oncology 16: 576-580.
5. Hashemy SI, Ungerstedt JS, Avval F.Z., Holmgren A. (2006) Motexafin Gadolinium, a Tumor-selective Drug Targeting Thioredoxin Reductase and Ribonucleotide Reductase. Journal of Biological Chemistry 281: 10691-10697.
6. Forouzannia A, Richards GM, Khuntia D, Mehta M.P. (2007) Motexafin gadolinium: a novel radiosensitizer for brain tumors. Expert Review of Anticancer Therapy 7: 785-794.
7. Berndt C, Kurz T, Bannenberg S., Jacob R, Holmgren A, et al (2011) Ascorbate and endocytosed Motexafin gadolinium induce lysosomal rupture. Cancer Letters 307: 119-123.
8. Donnelly ET, Liu Y, Fatunmbi Y.O., Lee I., Magda D, et al. (2004) Effects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors. Int J Radiat Oncol Biol Phys 58: 1570-1576.
9. Carde P, Timmerman R, Mehta M.P., Koprowski CD, Ford J, et al. (2001) Multicenter Phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. Journal of Clinical Oncology 19: 2074-2083.
10. Joh DY, Sun L, Stangl M., Al Zaki A, Murty S, et al (2013) Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization. PLoS ONE 8: e62425.
11. Hainfeld JF, Slatkin DN, Smilowitz H.M. (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49: N309.
12. Prezado Y, Fois G, Le Duc G, Bravin A. (2009) Gadolinium dose enhancement studies in microbeam radiation therapy. Med Phys 36: 3568-3574.
13. Bahreyni Toossi M., Ghorbani M, Mehrpouyan M., Akbari F, Sobhkhiz Sabet L, et al. (2012) A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles. Australasian Physical and Engineering Sciences in Medicine 35: 177-185.
14. Berbeco RI, Ngwa W, Makrigiorgos G.M. (2011) Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys 81: 270-276.
15. Cho SH (2005) Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol 50: N163-N173.
16. Jones BL, Krishnan S, Cho S.H. (2010) Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Med Phys 37: 3809-3816.
17. Rahman WN, Bishara N, Ackerly T., He CF, Jackson P, et al. (2009) Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine: Nanotechnology, Biology and Medicine 5: 136-142.
18. Leung MKK, Chow JCL, Chithrani BD, Lee MJG, Oms B, et al (2011) Irradiation of gold nanoparticles by x-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production. Med Phys 38: 624-631.
19. de Rochefort L., Nguyen T, Brown R., Spincemaille P, Choi G, et al (2008) In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med Phys 35: 5328-5339.
20. Dalaryd M, Kragl G, Ceberg C., Georg D, McClean B, et al (2010) A Monte Carlo study of a flattening filter-free linear accelerator verified with measurements. Phys Med Biol 55: 7333-7344.
21. Javedan K, Feygelman V, Zhang R.R., Moros EG, Correa CR, et al. (2014) Monte Carlo comparison of superficial dose between flattening filter free and flattened beams. Physica medica 30: 503-508.
22. Zhang RR, Feygelman V, Harris E.R., Rao N., Moros EG, et al. (2013) Is wax equivalent to tissue in electron conformal therapy planning? A Monte Carlo study of material approximation introduced dose difference. J Appl Clin Med Phys 14: 92-101.
23. Hsu S-M, Wu C-H, Lee J-H, Hsieh Y-J, Yu C-Y, et al. (2012) A Study on the Dose Distributions in Various Materials from an Ir-192 HDR Brachytherapy Source. PLoS ONE 7: e44528.
24. Rogers DWO, Faddegon BA, Ding G.X., Ma C-M, We J, et al (1995) BEAM: A Monte Carlo code to simulate radiotherapy treatment units. Med Phys 22: 503-524.
25. Kawrakow I (2000) Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. Med Phys 27: 485-498.
26. Kawrakow I, Walters BRB (2006) Efficient photon beam dose calculations using DOSXYZnrc with BEAMnrc. Med Phys 33: 3046-3056.
27. Constantin M, Perl J, LoSasso T., Keall P.J. (2011) Modeling the TrueBeam linac using a CAD to Geant4 geometry implementation: Dose and IAEA-compliant phase space calculations. Med Phys 38: 4018-4024.
28. Nath R, Anderson LL, Luxton G, Weaver K.A., Williamson JF, et al. (1995) Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 22: 209-234.
29. Saini AS, Zhang GG, Finkelstein S.E., Biagioli M.C. (2011) Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment. Int J Radiat Oncol Biol Phys 80: 1263-1267.